Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 91 clinical trials
Featured trial
Study to Assess the Efficacy Safety and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) (AERIFY-2)  

itepekimab compared with placebo on respiratory symptoms in former smokers with moderate-to-severe COPD Evaluate the efficacy of itepekimab compared with placebo on Forced Expiratory Volume in 1

  • 82 views
  • 12 Nov, 2021
  • 11 locations
Featured trial
Upper Respiratory Symptoms Research Study

Upper Respiratory Symptoms Research Study

  • 620 views
  • 23 Nov, 2020
  • 1 location
Arbidol for COPD Exacerbations

receives matched placebo. When the subject has a new respiratory infection, original respiratory symptoms worsen, or fever (the lower body temperature is greater than 37.3), oral medication is given

  • 0 views
  • 23 Jan, 2021
  • 1 location
Effectiveness of Relaxation Techniques

The study aims to assess the validity of a relaxation app. This will be accomplished by obtaining self-report measures about mood and respiratory symptoms. We hypothesize that self-report in the

  • 0 views
  • 05 Feb, 2021
  • 1 location
Efficacy of Steroid Pulse Therapy in Acute Exacerbation of Idiopathic Pulmonary Fibrosis (AE-IPF) Admitted in ER

idiopathic pulmonary fibrosis, patients who visited the emergency room with dyspnea symptoms Patients within 1 month of exacerbation of respiratory symptoms Patients with increased GGO

  • 2 views
  • 18 Aug, 2021
Dual MRI for Cardiopulmonary COVID-19 Long Haulers

The next phase of the COVID-19 pandemic is likely to see a surge in an associated chronic cardiopulmonary disease that will challenge health systems. Recovered patients are presenting with persistent dyspnea at the Duke Pulmonary Post-COVID clinic. Evidence is now mounting that recovered patients have significant residual pulmonary disease, while …

  • 0 views
  • 26 Sep, 2021
  • 1 location
Safety, Tolerability and Efficacy of Uproleselan (GMI-1271) in Patients With COVID-19 Pneumonia

The purpose of this study is to find out whether the drug uproleselan can help patients with severe COVID-19 pneumonia. Investigators will study both the side effects of the drug and assess if the drug will help patients recover more quickly and slow down the progression of acute respiratory failure.

  • 0 views
  • 15 Dec, 2021
  • 1 location
A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment na ve Subjects With Chronic Pulmonary Aspergillosis

The current initial therapy for CPA is with six months of oral itraconazole. However, the response with six months of therapy has a response rate of 65-70% and has a relapse rate after stopping treatment of up to 50%. Voriconazole is a third-generation azole and a theoretical advantage of lower …

  • 7 views
  • 21 Oct, 2021
  • 2 locations
Clinical Study of Recombinant Novel Coronavirus COVID-19 Vaccine (CHO Cell) Combined With Influenza Vaccine

Popular topicClinical study of recombinant Novel Coronavirus vaccine (CHO cell) combined with influenza vaccine. Research purpose:Main purpose:To evaluate the immunogenicity of recombinant Novel Coronavirus vaccine (CHO cells) combined with influenza vaccine in people aged 18 years and over. Secondary purpose:To evaluate the safety of recombinant Novel Coronavirus vaccine (CHO cells) …

Accepts healthy volunteers
  • 0 views
  • 10 Nov, 2021
  • 1 location
Amantadine for COVID-19

Introduction Corona virus disease 19 (COVID-19) is a devastating pandemic. By early February 2021, more than 102 million people were infected globally with more than 2.2 million reported deaths. Current treatments are approved for hospitalized patients with severe COVID-19 only. No treatment is approved to prevent progression to severe COVID-19 …

  • 0 views
  • 17 Oct, 2021
  • 1 location